Abstract
The current status of the use of estrogen receptor protein assays in the management of patients with breast cancer is reviewed. The use of other biochemical techniques to improve further the accuracy of this assay, and antiestrogens, a group of drugs useful to the oncologist, are also discussed.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
